Home LiteratureArticle Details
PMID: 9204910 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes.

Kulak JM, Nguyen TA, Olivera BM, McIntosh JM

Abstract

Activation of presynaptic nicotinic acetylcholine receptors (nAChRs) can induce the release of neurotransmitters such as dopamine and norepinephrine in the CNS. Accumulating evidence suggests that distinct nAChR subtypes are involved; however, it has been difficult to determine the subunit composition of these receptors, in part because of the lack of a sufficient variety of selective nAChR ligands. We present experimental data that at least two different nAChR complexes are involved in dopamine release, one of which has an alpha3/beta2 subunit interface. The recently discovered peptide alpha-conotoxin MII is a potent and selective inhibitor of rat nAChRs containing an interface formed by alpha3 and beta2 subunits. We used this peptide to examine nicotine-stimulated release of dopamine from rat striatal synaptosomes and of norepinephrine from hippocampal synaptosomes. MII (100 nM) blocks 34-49% of the nicotine-stimulated dopamine release, but not dopamine release evoked by elevated [K+]. Furthermore, two peptides structurally related to alpha-conotoxin MII, namely alpha-conotoxin MI (selective for alpha1beta1gammadelta nAChRs) and alpha-conotoxin ImI (selective for alpha7-containing nAChRs), have no effect on nicotine-stimulated dopamine release. The results indicate that one third to half of the dopamine release in the striatal preparation is mediated by nAChRs with an alpha3/beta2 subunit interface. In contrast, </=10% of nicotine-stimulated release of norepinephrine from hippocampal synaptosomes is modulated by nAChRs with alpha3/beta2 subunit interfaces.

MeSH Terms
Animals Conotoxins Dopamine/metabolism Dose-Response Relationship, Drug Male Mollusk Venoms/pharmacology Nicotine/pharmacology Peptides/pharmacology Rats Rats, Sprague-Dawley Synaptosomes/drug effects Visual Cortex/drug effects
Chemicals
Conotoxins Mollusk Venoms Peptides alpha-conotoxin MII Nicotine Dopamine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kulak J M
Department of Biology, University of Utah, Salt Lake City, Utah, 84112, USA.
Nguyen T A
Olivera B M
McIntosh J M
References (39)
39 references, click to expand
  1. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations.
    J Neurochem. 1990 Aug;55(2):632-40 PMID: 1973456
  2. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro.
    Neuroscience. 1993 Sep;56(1):23-32 PMID: 7901807
  3. Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum.
    Neurosci Lett. 1989 Apr 10;98(3):310-6 PMID: 2566962
  4. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    J Pharmacol Exp Ther. 1995 Jul;274(1):224-30 PMID: 7542334
  5. The role of dopamine in drug abuse viewed from the perspective of its role in motivation.
    Drug Alcohol Depend. 1995 May;38(2):95-137 PMID: 7671769
  6. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.
    Annu Rev Physiol. 1995;57:521-46 PMID: 7778876
  7. Nicotine gum and haloperidol in Tourette's syndrome.
    Lancet. 1988 Mar 12;1(8585):592 PMID: 2894527
  8. Glycosylation sites selectively interfere with alpha-toxin binding to the nicotinic acetylcholine receptor.
    J Biol Chem. 1994 Mar 18;269(11):8108-14 PMID: 7907588
  9. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions.
    J Biol Chem. 1995 Mar 3;270(9):4424-31 PMID: 7876208
  10. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
    Br J Pharmacol. 1994 Feb;111(2):406-13 PMID: 8004384
  11. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.
    Am J Epidemiol. 1994 Jun 15;139(12):1129-38 PMID: 8209872
  12. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Br J Pharmacol. 1996 Feb;117(4):595-606 PMID: 8646402
  13. The amino terminal half of the nicotinic beta-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxin.
    Proc Biol Sci. 1993 May 22;252(1334):141-8 PMID: 8391703
  14. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels.
    Nature. 1996 Mar 28;380(6572):347-51 PMID: 8598930
  15. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation.
    J Neurochem. 1988 Apr;50(4):1123-30 PMID: 3346670
  16. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography.
    J Neural Transm Park Dis Dement Sect. 1990;2(3):215-24 PMID: 2257061
  17. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.
    Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):587-92 PMID: 9012828
  18. Inhibition of nicotinic acetylcholine receptors by bis (2,2,6,6-tetramethyl- 4-piperidinyl) sebacate (Tinuvin 770), an additive to medical plastics.
    J Pharmacol Exp Ther. 1994 Feb;268(2):718-26 PMID: 8113983
  19. alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
    Mol Pharmacol. 1995 Aug;48(2):194-9 PMID: 7651351
  20. Affinity of native kappa-bungarotoxin and site-directed mutants for the muscle nicotinic acetylcholine receptor.
    Biochemistry. 1994 Nov 8;33(44):12962-7 PMID: 7947700
  21. Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system.
    J Neurosci. 1991 Aug;11(8):2588-97 PMID: 1869929
  22. alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
    Mol Pharmacol. 1995 Jul;48(1):105-11 PMID: 7623764
  23. Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes.
    J Neurochem. 1984 Dec;43(6):1593-8 PMID: 6149266
  24. Hippocampal synaptic transmission enhanced by low concentrations of nicotine.
    Nature. 1996 Oct 24;383(6602):713-6 PMID: 8878480
  25. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.
    J Neurosci. 1991 Mar;11(3):837-45 PMID: 1705971
  26. The role of nicotinic receptors in the pathophysiology of Alzheimer's disease.
    Prog Brain Res. 1989;79:353-62 PMID: 2685906
  27. Hippocampal nicotinic autoreceptors modulate acetylcholine release.
    Biochem Soc Trans. 1993 May;21(2):429-31 PMID: 8359505
  28. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain.
    J Neurochem. 1989 Feb;52(2):483-91 PMID: 2911027
  29. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Acta Physiol Scand. 1988 Apr;132(4):589-91 PMID: 3265840
  30. alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity.
    Biochemistry. 1995 Nov 7;34(44):14519-26 PMID: 7578057
  31. Schizophrenia and nicotinic receptors.
    Harv Rev Psychiatry. 1994 Nov-Dec;2(4):179-92 PMID: 9384901
  32. Presynaptic nicotinic ACh receptors.
    Trends Neurosci. 1997 Feb;20(2):92-8 PMID: 9023878
  33. A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
    J Biol Chem. 1996 Mar 29;271(13):7522-8 PMID: 8631783
  34. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
    Nature. 1996 Jul 18;382(6588):255-7 PMID: 8717040
  35. Drugs of abuse: anatomy, pharmacology and function of reward pathways.
    Trends Pharmacol Sci. 1992 May;13(5):177-84 PMID: 1604710
  36. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome.
    Biomed Pharmacother. 1989;43(1):19-23 PMID: 2730949
  37. Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors.
    Mol Pharmacol. 1997 Feb;51(2):336-42 PMID: 9203640
  38. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits.
    J Biol Chem. 1996 Jul 26;271(30):17656-65 PMID: 8663494
  39. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.
    J Neurochem. 1992 Sep;59(3):848-56 PMID: 1494911
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
0270-6474
Published
1997-07-15
Pages
5263-70
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6793802
Subset
IM
Grants
NIGMS NIH HHS · GM 48677 · United States
NIMH NIH HHS · MH 00929 · United States
NIMH NIH HHS · MH 53631 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]